Canada markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
37.16+0.19 (+0.51%)
At close: 4:02PM EDT

37.19 +0.03 (0.08%)
After hours: 7:59PM EDT

Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
41,908,000
41,908,000
51,750,000
53,647,000
52,546,000
Cost of Revenue
8,692,000
8,692,000
10,219,000
11,248,000
11,240,000
Gross Profit
33,216,000
33,216,000
41,531,000
42,399,000
41,306,000
Operating Expenses
Research Development
9,405,000
9,405,000
8,650,000
8,006,000
7,657,000
Selling General and Administrative
11,615,000
11,615,000
14,350,000
14,455,000
14,784,000
Total Operating Expenses
24,456,000
24,456,000
27,610,000
27,354,000
27,199,000
Operating Income or Loss
8,760,000
8,760,000
13,921,000
15,045,000
14,107,000
Interest Expense
1,449,000
1,449,000
1,574,000
1,316,000
1,270,000
Total Other Income/Expenses Net
113,000
113,000
5,108,000
-2,178,000
-923,000
Income Before Tax
7,497,000
7,497,000
17,682,000
11,885,000
12,305,000
Income Tax Expense
477,000
477,000
1,384,000
706,000
-9,049,000
Income from Continuing Operations
7,021,000
7,021,000
16,298,000
11,179,000
21,353,000
Net Income
9,616,000
9,616,000
16,273,000
11,153,000
21,308,000
Net Income available to common shareholders
9,616,000
9,616,000
16,272,000
11,152,000
21,307,000
Basic EPS
-
-
2.92
1.90
3.57
Diluted EPS
-
-
2.87
1.87
3.52
Basic Average Shares
-
-
5,569,000
5,872,000
5,970,000
Diluted Average Shares
-
-
5,675,000
5,977,000
6,058,000
EBITDA
-
13,723,000
25,266,000
19,585,000
19,844,000